Redeye comments on GiG’s Q4-results where topline came in stronger than expected while EBITDA was so...
Redeye sees an overall solid Q4 report showing an impressive organic growth of 30%.
Kollect on Demand publicerade idag den 14 februari 2021 sin delårsrapport för fjärde kvartalet 2021.
Redeye comments on Invisio’s Q4-results which came in lower than expected while the company’s outloo...
Stark lönsamhet och trading update Omsättningen i Q4 uppgick till EUR 98,2m vilket var i linje med v...
Högre hyresintäkter men lägre förvaltningsresultat Hyresintäkterna för Q4'21 uppgick till 5,4 EURm (...
Accelererande organiskt tillväxt... Efterfrågan ökade tydligt för merparten av Midways bolag i Q4.
Redeye raises its forecasts and Base Case slightly following a, considering the conditions, solid Q4...
Redeye retains its positive view on Bredband2 following a Q4 report largely in line with our forecas...
OrderYOYO has over the past six years built a market leading position in the European market regardi...
Mangold uppdaterar läkemedelsutvecklaren Double Bond Pharma (DBP).
Nitro Games delivered a solid report, revenue was 1% ahead of our expectations, while EBIT was 45% a...
EAB reported H2 comparable operating income of EUR 11.
Rovio's Q4 performance exceeded our expectations and guidance for 2022 provided further confidence i...
Redeye comments on today’s updated schedule for Orphazyme’s planned NDA resubmission with arimoclomo...
Redeye comments on GiG’s extended contract with Betsson which now runs to Q4 25 which lowers risk an...
Redeye is encouraged to see another surprisingly strong quarter with sales beating our expectations ...
Electra Gruppen ökade nettoresultatet med hela 31 procent för helåret och nu riktas fokuset mot samm...
Redeye comments on Alligator Bioscience’s end-of-year report.
Redeye gives a short comment on today’s January ARR update from Hoylu.
